ANEXT (China) Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 3

ANEXT (China) General Information

Description

Developer of new drugs and delivery methods designed for anti-aging and reversing aging purposes. The company can realize the development of new drugs and change the conventional drug delivery methods to obtain highly optimized cell therapy methods through the newly discovered "naturally domesticated" biomolecule drug carriers Exosomes and engineering transformation, providing customers with reliable and creative products.

Contact Information

Website
www.anextcell.com
Formerly Known As
Shanghai Rubi Culture Communication Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 2, No. 1788, Huifeng West Road, Jinhai Community
  • Fengxian District
  • Shanghai, 201400
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
LOHAS & Wellness, Beauty, Life Sciences
Corporate Office
  • Building 2, No. 1788, Huifeng West Road, Jinhai Community
  • Fengxian District
  • Shanghai, 201400
  • China
+86 021

ANEXT (China) Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ANEXT (China) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 17-Dec-2024 Completed Generating Revenue
5. Secondary Transaction - Private 04-Aug-2024 Completed Generating Revenue
4. Later Stage VC 29-Dec-2023 Completed Generating Revenue
3. Later Stage VC 01-May-2023 Completed Generating Revenue
2. Later Stage VC 30-Sep-2022 Completed Generating Revenue
1. Later Stage VC 01-Jan-2020 Completed Generating Revenue
To view ANEXT (China)’s complete valuation and funding history, request access »

ANEXT (China) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ANEXT (China) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Huayi Capital Venture Capital Minority
Shanghai Huamin Investment Management Growth/Expansion Minority
Huilian Investment Asset Manager Minority
To view ANEXT (China)’s complete investors history, request access »

Ready to get started?

Request a free trial

ANEXT (China) FAQs

  • When was ANEXT (China) founded?

    ANEXT (China) was founded in 2013.

  • Where is ANEXT (China) headquartered?

    ANEXT (China) is headquartered in Shanghai, China.

  • What is the size of ANEXT (China)?

    ANEXT (China) has 2 total employees.

  • What industry is ANEXT (China) in?

    ANEXT (China)’s primary industry is Drug Discovery.

  • Is ANEXT (China) a private or public company?

    ANEXT (China) is a Private company.

  • What is ANEXT (China)’s current revenue?

    The current revenue for ANEXT (China) is .

  • How much funding has ANEXT (China) raised over time?

    ANEXT (China) has raised $14M.

  • Who are ANEXT (China)’s investors?

    Huayi Capital, Shanghai Huamin Investment Management, and Huilian Investment have invested in ANEXT (China).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process